Kanarb (Fimasartan)

Kanarb (fimasartan) is a blood pressure tablet approved in South Korea in 2010 for essential hypertension. Its Korean label also allows it to reduce protein in the urine for people who have both high blood pressure and type 2 diabetic kidney disease. Most adults start on 30 or 60 mg once a day, and the dose can go up to 120 mg.

Fimasartan blocks the angiotensin II type 1 (AT1) receptor, so angiotensin II can no longer narrow the blood vessels or make the body hold on to salt and water. Blood pressure begins to fall within about 2 weeks, and the full effect is seen after 8–12 weeks.

• Not to be used in pregnancy or while breastfeeding. Stop and contact the doctor as soon as a pregnancy is confirmed.
• Not for patients on dialysis, or with moderate to severe liver disease or biliary obstruction. In severe kidney impairment the dose should not go above 60 mg.
• Do not combine with aliskiren in diabetes or reduced kidney function, or with an ACE inhibitor in diabetic kidney disease. Potassium and kidney function should be checked.
• The tablets contain lactose and the yellow dye tartrazine. Dizziness can occur, especially when treatment starts.

Can Kanarb be imported to India?

Yes. If a cardiologist or physician prescribes Kanarb, it can be imported for that patient under the named-patient route.

Which strength should be ordered?

There are three strengths: 30 mg, 60 mg and 120 mg. People over 70, people taking high-dose diuretics and people with severe kidney impairment start on 30 mg. Most others start on 30 or 60 mg. The doctor should write the strength on the prescription.

What documents do we need?

• A prescription from a cardiologist or physician stating the strength and number of tablets
• A short note on the blood pressure history (and kidney reports, if it is for diabetic kidney disease)
• Government-issued photo ID of the patient

We confirm the order only after the prescription has been checked.

How is Kanarb packed and stored?

In Korea the tablets come in bottles of 30 or 300, so one bottle of 30 is a month’s supply. Store at room temperature (1–30 °C) in a tightly closed container away from light. The shelf life is 3 years.

Kanarb is a long-term medicine, so most families ask for several months at a time. We source it from Korean supply channels and check the expiry date for longer orders.

For Kanarb price in India, call +91-9310090915 or email info@indianpharmanetwork.in.

Global Approval Status:

• South Korea: Approved in September 2010 (prescription-only).
• Singapore: Registered (Kanarb 60 mg).
• United States / European Union: Not approved.

Sources:

• Kanarb 60 mg – product label on the MFDS drug database (Korea)
• Kanarb 60 mg – Korea Pharmaceutical Information Center (health.kr)
• Kanarb Tablet 60 mg – Singapore National Drug Formulary (SIN15221P)

Information last checked: October 2026.

What does Kanarb treat?

It is an angiotensin II receptor blocker (ARB), prescribed for essential hypertension.

Which company makes Kanarb?

Boryung Co., Ltd. (South Korea).

Is Kanarb similar to losartan or telmisartan?

Yes, it belongs to the same group of medicines (angiotensin receptor blockers), but fimasartan is a different molecule. Switching between them is the doctor’s decision.

What is the mechanism of Kanarb?

Fimasartan blocks the angiotensin II type 1 (AT1) receptor, so angiotensin II can no longer narrow the blood vessels or make the body hold on to salt and water.

I am over 70. Is my Kanarb dose different?

Yes. The Korean label recommends starting on 30 mg once a day for patients over 70. The doctor can then raise the dose as needed, up to 120 mg.

Does Kanarb have FDA approval?

No. Kanarb is not approved by the US FDA.